Skip to main content
. 2021 Nov 20;13(11):1970. doi: 10.3390/pharmaceutics13111970

Figure 4.

Figure 4

MC simulation: Impact of eGFR6, Tac IPV, and mean C0/D during 6–12 months after Tx on long-term kidney function in patients without AR (a,b) and with AR (c,d).